These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 15694183)
1. What is remission in follicular lymphoma and what is its relevance? Buckstein R; Pennell N; Berinstein NL Best Pract Res Clin Haematol; 2005 Mar; 18(1):27-56. PubMed ID: 15694183 [TBL] [Abstract][Full Text] [Related]
2. [Minimal residual disease in follicular and mantle cell lymphoma. Detection using quantitative molecular monitoring of circulating lymphoma cells]. Schüler F; Hirt C; Dölken L; Krüger W; Dölken G Dtsch Med Wochenschr; 2005 Sep; 130(38):2130-4. PubMed ID: 16172952 [TBL] [Abstract][Full Text] [Related]
3. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients. Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272 [TBL] [Abstract][Full Text] [Related]
4. [Achieving Bcl-2/IgH negativity in peripheral blood/bone marrow after therapy implies better prognosis for patients with follicular lymphoma]. Belada D; Smolej L; Stepánková P; Beránek M; Dvoráková D; Bukac J; Malý J Vnitr Lek; 2007 Oct; 53(10):1057-63. PubMed ID: 18072430 [TBL] [Abstract][Full Text] [Related]
5. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy. Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339 [TBL] [Abstract][Full Text] [Related]
10. One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near? Schmitt C; Grundt A; Buchholtz C; Scheuer L; Benner A; Hensel M; Ho AD; Leo E Leuk Res; 2006 Dec; 30(12):1563-8. PubMed ID: 16530831 [TBL] [Abstract][Full Text] [Related]
12. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. Federico M; Bellei M; Marcheselli L; Luminari S; Lopez-Guillermo A; Vitolo U; Pro B; Pileri S; Pulsoni A; Soubeyran P; Cortelazzo S; Martinelli G; Martelli M; Rigacci L; Arcaini L; Di Raimondo F; Merli F; Sabattini E; McLaughlin P; Solal-Céligny P J Clin Oncol; 2009 Sep; 27(27):4555-62. PubMed ID: 19652063 [TBL] [Abstract][Full Text] [Related]
13. Follicular lymphoma: clinical features and treatment. Tan D; Horning SJ Hematol Oncol Clin North Am; 2008 Oct; 22(5):863-82, viii. PubMed ID: 18954741 [TBL] [Abstract][Full Text] [Related]
14. The role of mitoxantrone in the treatment of indolent lymphomas. Hagemeister F; Cabanillas F; Coleman M; Gregory SA; Zinzani PL Oncologist; 2005 Feb; 10(2):150-9. PubMed ID: 15709217 [TBL] [Abstract][Full Text] [Related]
15. Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma. Sacchi S; Pozzi S; Marcheselli R; Federico M; Tucci A; Merli F; Orsucci L; Liberati M; Vallisa D; Brugiatelli M; Cancer; 2007 Jul; 110(1):121-8. PubMed ID: 17503433 [TBL] [Abstract][Full Text] [Related]
16. Anti-idiotypic Immunotherapy in follicular lymphoma patients: results of a long follow-up study. Yáñez R; Barrios Y; Ruiz E; Cabrera R; Díaz-Espada F J Immunother; 2008 Apr; 31(3):310-2. PubMed ID: 18317357 [TBL] [Abstract][Full Text] [Related]
17. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group. Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G; J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481 [TBL] [Abstract][Full Text] [Related]
18. Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma. Hicks LK; Woods A; Buckstein R; Mangel J; Pennell N; Zhang L; Imrie K; Spaner D; Cheung MC; Boudreau A; Reis M; Crump M; Berinstein NL Bone Marrow Transplant; 2009 May; 43(9):701-8. PubMed ID: 19029963 [TBL] [Abstract][Full Text] [Related]
19. First-line treatment of follicular lymphoma in the era of monoclonal antibodies. Coiffier B Clin Adv Hematol Oncol; 2005 Jun; 3(6):484-91, 505. PubMed ID: 16167027 [TBL] [Abstract][Full Text] [Related]
20. Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma. Kang TY; Rybicki LA; Bolwell BJ; Thakkar SG; Brown S; Dean R; Sekeres MA; Advani A; Sobecks R; Kalaycio M; Pohlman B; Sweetenham JW Bone Marrow Transplant; 2007 Nov; 40(10):973-8. PubMed ID: 17873917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]